BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22284268)

  • 1. Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.
    Dong W; Liu W; Yan Z; Liao X; Guan B; Wang N; Liu Z
    Eur J Med Chem; 2012 Mar; 49():239-44. PubMed ID: 22284268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and cytotoxicity of novel hexacyclic saframycin-ecteinascidin analogs.
    Lu X; Pan X; Guan B; Liu Z
    Org Biomol Chem; 2020 Jan; 18(2):237-249. PubMed ID: 31782476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa.
    Guo J; Dong W; Liu W; Yan Z; Wang N; Liu Z
    Eur J Med Chem; 2013 Apr; 62():670-6. PubMed ID: 23434640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective synthesis of saframycin A and evaluation of antitumor activity relative to ecteinascidin/saframycin hybrids.
    Martinez EJ; Corey EJ
    Org Lett; 1999 Jul; 1(1):75-7. PubMed ID: 10822537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cytotoxic activity of new jadomycin derivatives reveals the potential to improve its selectivity against tumor cells.
    Fan K; Zhang X; Liu H; Han H; Luo Y; Wang Q; Geng M; Yang K
    J Antibiot (Tokyo); 2012 Sep; 65(9):449-52. PubMed ID: 22714025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs.
    Liu ZZ; Wang Y; Tang YF; Chen SZ; Chen XG; Li HY
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1282-5. PubMed ID: 16338237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric total synthesis of (-)-saframycin A from L-tyrosine.
    Dong W; Liu W; Liao X; Guan B; Chen S; Liu Z
    J Org Chem; 2011 Jul; 76(13):5363-8. PubMed ID: 21612294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxicity of (-)-renieramycin G analogs.
    Liu W; Dong W; Liao X; Yan Z; Guan B; Wang N; Liu Z
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1419-21. PubMed ID: 21295980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxicity of a novel series of saframycin-ecteinascidin analogs containing tetrahydro-β-carboline moieties.
    Lu X; Pan X; Yang Y; Ji M; Chen X; Xiao Z; Liu Z
    Eur J Med Chem; 2017 Jul; 135():260-269. PubMed ID: 28456034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of saframycins. X. Transformation of (-)-saframycin A to (-)-saframycin Mx type compound with the structure proposed for saframycin E.
    Saito N; Harada S; Nishida M; Inouye I; Kubo A
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):777-82. PubMed ID: 7553964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrazidomycins, cytotoxic alkylhydrazides from Streptomycesatratus.
    Ueberschaar N; Ndejouong Ble S; Ding L; Maier A; Fiebig HH; Hertweck C
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5839-41. PubMed ID: 21868221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
    Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
    Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs.
    Yang Y; Gao Y; Chen S; Guo J; Hu Y
    Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300453. PubMed ID: 37814371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel compounds related to 1-arylnaphthalene lignans and isoquinolines.
    Ding H; Lu W; Li H; Yang L; Zhang Q; Zhou C; Wu X; Baudoin O; Cai J; Guéritte F; Zhao Y
    Chem Biodivers; 2005 Sep; 2(9):1217-31. PubMed ID: 17193204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
    Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
    Zhang J; Li Y; Sun J; Li W; Gong Y; Zheng X; Cui J; Wang R; Wu J
    Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics.
    Scott JD; Williams RM
    Chem Rev; 2002 May; 102(5):1669-730. PubMed ID: 11996547
    [No Abstract]   [Full Text] [Related]  

  • 18. HS071, a new furan-type cytotoxic metabolite from Streptomyces sp. HS-HY-071.
    Wang J; Zhang H; Yang X; Zhou Y; Wang H; Bai H
    J Antibiot (Tokyo); 2008 Oct; 61(10):623-6. PubMed ID: 19168976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
    Fan E; Shi W; Lowary TL
    J Org Chem; 2007 Apr; 72(8):2917-28. PubMed ID: 17373847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discovery and development of unknown potentialities of microorganisms with special reference to saframycin group antitumor antibiotics].
    Arai T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2617-24. PubMed ID: 6508318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.